elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
RNA interference
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
RNA interference
RIS
0.003
(Research Intensity Score)
Papers
288
Top papers
Kidney fibrosis: from mechanisms to therapeutic medicines
2023 · 746 citations
Therapeutic siRNA: state of the art
2020 · 1562 citations
Targeting circular RNAs as a therapeutic approach: current strategies and challenges
2021 · 573 citations
Gene therapy: Comprehensive overview and therapeutic applications
2022 · 325 citations
Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis
2021 · 337 citations
Newest papers
Nanoparticle-Assisted RNAi Targeting Small-Conductance Calcium-Activated Potassium Channels Enhances Insecticide Susceptibility and Disrupts Development in Spodoptera frugiperda
2026 · 2 citations
Yttrium Nitrate Exacerbates Oxidative Stress in the Mouse Epididymis by Inhibiting GPX5 Expression
2026 · 2 citations
Nano-enabled spray-induced RNA interference against fungal pathogens of oilseed crops: carrier performance, delivery evidence and field translation
2026
Investigation of the Nrf2-Keap1 signaling pathway's response to oxidative stress in Meretrix meretrix
2026
Nanocarrier‐mediated delivery of dsRNA targeting the ecdysone receptor enables non‐invasive RNAi control of ticks
2026
A sample from the 100 top papers behind RNA interference.
Create a free account to browse them all →
RNA interference's history
Research intensity over time
Explore RNA interference's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
RNA interference's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link